Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 443 of 1,261
  1. US 10556021

    Nanocarriers for drug delivery

    The Regents of the University of California · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  2. US 10556890

    Heteroaryl compounds and methods of use thereof

    PGI Drug Discovery LLC · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  3. US 10556256

    Antibacterial water

    Takeda Pharmaceutical Company Limited · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  4. US 10556860

    hTERT modulators and methods of use

    THE ARIZONA BOARD OF REGENTS · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  5. US 10557850

    Anti-CXCR1 compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  6. US 10555929

    Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

    Coherus BioSciences, Inc. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  7. US 10556001

    Thermal inactivation of rotavirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  8. US 10555963

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  9. US 10557139

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  10. US 10556945

    Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  11. US 10555960

    Use of an aminoglycoside for nonsense mutation suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  12. US 10557137

    Modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  13. US 10556916

    Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  14. US 10556881

    Nrf2 activating compounds and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  15. US 10555961

    Materials and methods for treating bacterial infections using C-1 gentamicin

    United States Government as represented by the Department of Veterans Affairs · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  16. US 10556861

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  17. US 10556897

    Protein kinase inhibitors

    Princeton Drug Discovery, Inc · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  18. US 10556875

    Bis-diazeniumdiolate compounds as anti-cancer agents

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  19. US 10556891

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  20. US 10558394

    Injectable flowable composition comprising buprenorphine

    Indivior UK Limited · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted
  21. CA 3103888

    PROCEDE DE PURIFICATION DE SULFATE D'ISAVUCONAZONIUM

    BASILEA PHARM INT AG [CH] · Granted Feb 6, 2020 · Expires Feb 1, 2040

    granted
  22. US 2020040086

    PHARMACEUTICAL COMBINATIONS COMPRISING AN ANTI-LY75 ANTIBODY

    BERLIN CHEMIE AG [DE] · Granted Feb 6, 2020 · Expires Feb 1, 2040

    granted
  23. US 10548886

    Methods of treatment using a JAK inhibitor compound

    Theravance Biopharma R&D IP, LLC · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted
  24. US 10550164

    Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.